3545 results for «201»
3545 results
Understanding how to use evidence in clinical practice
14 May 2024 – From EuroPCR 2024
This session focuses on understanding how to apply the latest evidence and clinical guidelines in daily practice for Non-Interventional Cardiologists (NAPs). It covers the influence of patient-reported outcomes on cardiovascular clinical practices, the translation of the 2023 ACS clinical guidelines into NAP's practice, the impact of...

Expanding the indications of DCB for complex PCI scenarios
14 May 2024 – From EuroPCR 2024
This session, with the collaboration of various national societies, explores the use of drug-coated balloons (DCBs) in complex PCI scenarios, such as multivessel disease, left main, bifurcations, CTOs, or myocardial infarction. It includes case presentations and discussions on the procedural techniques, patient selection, and lesion preparation...

Align for the future with next-generation balloon expandable transcatheter heart valve technology
14 May 2024 – From EuroPCR 2024
Tune in to this EuroPCR 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for...

When and how to treat the side branch in non-left main bifurcations?
14 May 2024 – From EuroPCR 2024
Explore this video session covering essential techniques for handling bifurcations in coronary interventions. Learn to evaluate side branch significance and the need for a second stent, illustrated through three case studies. Discover main vessel stenting for a large side branch, various approaches like T-stenting, TAP, or...

Hotline: advances in coronary physiology
14 May 2024 – From EuroPCR 2024
This hotline session explores the latest advancements in coronary physiology and their implications for percutaneous coronary intervention (PCI). Topics covered include the influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI, the prognostic value of myocardial ischemic burden in STEMI...

Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...

Different treatment options for PCI in calcified lesions
15 May 2024 – From EuroPCR 2024
This session showcases various treatment options for percutaneous coronary intervention (PCI) in calcified lesions. Attendees will learn about the use of excimer laser atherectomy, intravascular lithotripsy, and other techniques to effectively manage challenging calcified coronary lesions. The session features case presentations and discussions, providing insights into...

Treatment strategies in complex coronary
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex coronary intervention cases from the EuroPCR 2024 Clinical Case submissions. The cases cover a range of challenging scenarios, including CTO with left ventricular dysfunction and VT storm, subintimal tracking and re-entry, and the decision between native vessel CTO PCI...

NSTEMI in patients in post CABG: a challenging combination
15 May 2024 – From EuroPCR 2024
This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...

Stentless PCI
15 May 2024 – From EuroPCR 2024
This session explores various stentless percutaneous coronary intervention (PCI) strategies, including drug-coated balloon (DCB)-only PCI for chronic total occlusions and de-novo coronary lesions, as well as the use of magnesium resorbable scaffolds. Attendees will learn about the rationale, techniques, and outcomes of these "leave nothing behind"...

Endovascular treatment for acute chronic heart failure
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex endovascular cases for the treatment of acute chronic heart failure, including the use of 3D printing and virtual reality to close a pulmonary arteriovenous malformation, closure of a post-septal myectomy ventricular septal defect, and catheter-based treatment of a heart...

Treating the right valves: not always a straightforward task
15 May 2024 – From EuroPCR 2024
This session focuses on the challenges and complexities involved in the percutaneous treatment of right-sided heart valves, including the tricuspid and pulmonary valves. Attendees will learn from case presentations and discussions on various scenarios, such as recurrent right heart obstructive shock, paravalvular leak closure, and unusual...

PCI complications: device-related issues, perforations and other unexpected events
15 May 2024 – From EuroPCR 2024
This session focuses on the management of various complications that can occur during percutaneous coronary intervention (PCI), including device-related issues, perforations, and other unexpected events. Attendees will learn from case presentations and discussions on strategies to identify, mitigate, and manage these complications, with a focus on...

Innovating techniques for the treatment of coronary artery disease
14 May 2024 – From EuroPCR 2024
This session showcases innovative techniques for the treatment of coronary artery disease, including minimum contrast PCI with guide extension catheter and IVUS co-registration, management of iatrogenic aortic dissection using 3D-hologram and computational fluid dynamics, a novel tunnelling technique for huge coronary bypass graft aneurysms, and a...

Innovations and novel strategies in CTO PCI
15 May 2024 – From EuroPCR 2024
This session showcases innovative and novel strategies for the percutaneous treatment of chronic total occlusions (CTO) in the coronary arteries. Attendees will learn about techniques such as subintimal rotational ablation with retrograde guidance, external calcium modification, and the use of intravascular lithotripsy to optimize stenting in...

TAVI in bicuspid stenosis: complex situations
14 May 2024 – From EuroPCR 2024
This session comprises selected clinical case submissions focused on TAVI (Transcatheter Aortic Valve Implantation) in patients with bicuspid aortic stenosis. Participants will learn about complex scenarios, including fusion raphe, hostile bicuspid anatomy, large annulus, and early TAVR dysfunction. The session features case presentations followed by audience...

Management complications during PCI of calcified coronary lesions
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions showcasing the management of complications that can arise during PCI (Percutaneous Coronary Intervention) of calcified coronary lesions. Participants will learn about various challenging scenarios, such as impacted diamond crown, stuck IVUS catheter post-stenting, and ruptured/fractured cutting balloon. The session...

Undilatable calcified lesion with balloon - LIVE case
15 May 2024 – From EuroPCR 2024
A 66-year-old male with a history of PAD, COPD, diabetes, and an LV function of 44% presented with unstable angina. Coronary angiography revealed a severe and heavily calcified RCA lesion undilatable with a balloon. The patient was referred to a centre specializing in calcified lesion treatment.
Using...

Post PCI anti-thrombotic strategies
15 May 2024 – From EuroPCR 2024

Challenging scenarios in STEMI
14 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions highlighting challenging scenarios in the management of STEMI (ST-Elevation Myocardial Infarction) patients. Participants will learn about complex cases, such as left main time bomb, coronary anomalies, simultaneous two-vessel acute coronary thrombosis, and mechanical complications. The session includes case presentations...
